rosiglitazone has been researched along with propiconazole in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bell, A; Gagnon, A; Koumas, L; Phipps, RP; Sempowski, GD; Smith, TJ; Sorisky, A | 1 |
| Bahn, RS; Dutton, CM; Harteneck, DA; Valyasevi, RW | 1 |
| Feldon, SE; Guo, N; Phipps, RP; Woeller, CF | 1 |
3 other study(ies) available for rosiglitazone and propiconazole
| Article | Year |
|---|---|
Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy.
Topics: Adipocytes; Cell Differentiation; Cells, Cultured; Connective Tissue; Fibroblasts; Flow Cytometry; Graves Disease; Humans; Immunohistochemistry; Orbit; Phenotype; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Thy-1 Antigens; Transcription Factors | 2002 |
Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts.
Topics: Adipocytes; Cell Differentiation; Cell Division; Cells, Cultured; Fibroblasts; Graves Disease; Humans; Orbit; Receptors, Cytoplasmic and Nuclear; Receptors, Thyrotropin; RNA, Messenger; Rosiglitazone; Stem Cells; Thiazoles; Thiazolidinediones; Transcription Factors | 2002 |
Peroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts.
Topics: Cell Adhesion; Cells, Cultured; Fibroblasts; Fibrosis; Glucuronosyltransferase; Humans; Hyaluronan Synthases; Hyaluronic Acid; Hypoglycemic Agents; Inflammation; Ligands; Orbit; Orbital Diseases; Pioglitazone; PPAR gamma; RNA, Messenger; Rosiglitazone; T-Lymphocytes; Thiazolidinediones; Transforming Growth Factor beta | 2011 |